Generic Alinia is used to treat diarrhea caused by certain parasites. ANI Pharmaceuticals is introducing nitazoxanide tablets ...

March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ...

4 analysts have expressed a variety of opinions on ANI Pharmaceuticals (NASDAQ:ANIP) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table ...

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that the U.S. Food and Drug Administration (FDA) has approved an ...

ANI Pharmaceuticals (ANIP) announced that the U.S. FDA has approved an expanded label for Iluvien that includes an indication for the treatment of chronic non-infectious uveitis affecting the ...

This segment also distributes bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names; and packages and distributes pharmaceuticals and vitamins to its retail and institutional ...

PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced U.S. Food and Drug Administration (FDA) approval of Purified ...

ANI Pharmaceuticals (NASDAQ:ANIP – Free Report) had its price target increased by Guggenheim from $84.00 to $86.00 in a research report sent to investors on Wednesday,Benzinga reports.